News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Jennifer Schwartz: Nabil Adra leading the IU School of Medicine Department of Medicine Division of Hematology-Oncology 2024 ASCO Review
Photo from Jennifer Schwartz/X
Jul 17, 2024, 00:12

Jennifer Schwartz: Nabil Adra leading the IU School of Medicine Department of Medicine Division of Hematology-Oncology 2024 ASCO Review

Jennifer Schwartz, Hematologist/Transplanter/Medical Educator at Indiana University School of Medicine, shared a post on X:   .

“Congratulations to Nabil Adra for leading the IU School of Medicine, IU School of Medicine Department of Medicine Division of Hematology-Oncology 2024 ASCO Review.

Thanks to our incredible faculty speakers who made it an informative and entertaining day!”

Source: Jennifer Schwartz/X

ASCO2024 cancer Hematology Oncology Hematology-Oncology 2024 ASCO Review Indiana University School of Medicine IU School of Medicine Department of Medicine Jennifer Schwartz Nabil Adra OncoDaily Oncology
Special Coverage
Blog
Nov 13, 2024, 11:34
Erika Hamilton: Inspired by the strength of the veteran patients and their commitment to continue fighting
Blog
Nov 13, 2024, 11:30
ABC Global Alliance - Learning more about brain metastases in breast cancer
Blog
Nov 13, 2024, 11:25
Some information you should know about lung cancer - American Cancer Society
Insight
Nov 13, 2024, 11:10
Myeloma Paper of the Day, November 13th, suggested by Robert Orlowski
Blog
Nov 13, 2024, 11:01
LGCW2024 session on Galvanising African cancer research building a strong cancer workforce - AORTIC- Africa
Blog
Nov 13, 2024, 10:59
Bernard Fox received SITC lifetime achievement award
Blog
Nov 13, 2024, 10:54
Hear Her campaign Increasing awareness about lung cancer in women
Blog
Nov 13, 2024, 10:52
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Blog
Nov 13, 2024, 10:47
FDA approves obecabtagene autoleucel for relapsed or refractory B-cell precursor ALL
Blog
Nov 13, 2024, 10:45
OncoInfluencers to Follow on Social Media: Dr. Nitin Jain
Insight
Nov 13, 2024, 10:37
UCLA: Combination approach shows promise for treating rare, aggressive cancers
Opinion
Nov 13, 2024, 10:32
The 6th Biennial Miami Epigenetics and Cancer Symposium to be held in Sylvester Comprehensive Cancer Center